Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia

PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study aimed to evaluate the role of decitabine as a first-line treatment for older adults with AML. MATER...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Yonsei Med J
Main Authors: Park, Hyunsung, Chung, Haerim, Lee, Jungyeon, Jang, Jieun, Kim, Yundeok, Kim, Soo Jeong, Kim, Jin Seok, Min, Yoo Hong, Cheong, June-Won
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122650/
https://ncbi.nlm.nih.gov/pubmed/27873493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.1.35
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados